This brand name is authorized in France
The drug EUPHON contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Codeine
UNII Q830PW7520 - CODEINE
|
|
Codeine is a centrally acting weak analgesic. Codeine exerts its effect through ฮผ opioid receptors, although codeine has low affinity for these receptors, and its analgesic effect is due to its conversion to morphine. Codeine, particularly in combination with other analgesics such as paracetamol, has been shown to be effective in acute nociceptive pain. The anti-tussive activity of codeine is probably due to its depressant effect on the medullary cough centre in the brain. |
|
2
Erysimum
UNII DF9242823M - SISYMBRIUM OFFICINALE TOP
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R05D | Cough suppressants, excl. combinations with expectorants | R Respiratory system → R05 Cough and cold preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de donnรฉes publique des mรฉdicaments | Identifier(s): 63283736 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
